Chronic Lymphocytic Leukemia Clinical Trial

Understanding Chronic Lymphocytic Leukemia

Summary

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of leukemia-cll/" >chronic lymphocytic leukemia.

View Full Description

Full Description

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
Any low grade lymphoproliferative disorder
Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

Exclusion Criteria:

-

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

2750

Study ID:

NCT04028531

Recruitment Status:

Recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States More Info
Jennifer Brown, MD, PhD
Contact
617-582-8437
[email protected]
Jennifer Brown, MD, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Chronic Lymphocytic Leukemia

Estimated Enrollment:

2750

Study ID:

NCT04028531

Recruitment Status:

Recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.